Yet, the underlying mechanisms linked to BAs as well as the assessment of Fxr- and Tgr5-deficient CD8+ T cell in the context of NASH or HCC remain to be subject of future work. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.